High Reliable and Environment Friendly Laboratory Freezer

106L -40℃ Portable Laboratory Freezer: Precision-engineered for critical biological storage at -40℃ with microcomputer-controlled temperature stability (≤0.1℃ resolution). Achieves rapid cooldown from 25℃ to -40℃ within 90 minutes and maintains ≤3℃ uniformity across all zones. The space-saving under-counter design (H×W×D: 85×60×70cm) features dual locking mechanisms and UL/CE safety certification. Optimized for plasma storage facilities, monoclonal antibody archives, and diagnostic laboratory reagent hubs.

308L -40℃ Biomedical Freezer: Precision storage for critical biologics at -40℃±0.5℃, achieving 180-minute cooldown (25℃→-40℃) with ≤3.9℃ spatial uniformity. Powered by R290 natural hydrocarbon refrigerant, featuring dual-stage cascade cooling and microprocessor stability control. CE/UL, FDA list certified for genomic library repositories, mRNA therapeutic vaults, and stem cell master cell banks.

518L -40℃ Laboratory Freezer： Precision-engineered for critical biomedical storage at -40℃ with ≤3℃ spatial uniformity and 180-minute rapid cooldown (25℃→-40℃, full load), featuring R290 natural hydrocarbon refrigerant and industrial-grade cascade cooling. CE safety certified, UL 250 listed, and FDA list for mission-critical applications: mRNA vaccine bulk storage (LNP stability >98%), freeze-dried plasma repositories (5-year preservation per WHO), CRISPR reagent hubs (gRNA activity >95% at -40℃), and bacteriophage therapy libraries (maintaining >10⁹ PFU/mL potency).

850L -40°C Upright Biomedical Freezer delivers mission-critical cryogenic storage for commercial bioproduction, maintaining -40°C stability with ≤3°C vertical stratification through dual independent cascade cooling circuits and achieving 220.8-minute rapid cooldown (25°C→-40°C at 220-240V/50Hz/60Hz) under full load, engineered with R290 natural hydrocarbon refrigerant; CE safety certified for industrial-scale applications including CAR-T cell commercial manufacturing, mRNA vaccine filling stations, continuous monoclonal antibody production, and synthetic biology raw material hubs.